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CASE STUDY
Severe fever with thrombocytopenia 
syndrome presenting as hemophagocytic 
syndrome: two case reports
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Abstract 
Introduction: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that was first 
reported in China in 2011. However, it is now endemic in Japan, and the SFTS viruses in Japan and China have evolved 
independently. Its fatality rate is 26.5 % in Japan, and the viral load is related to morbidity.
Case description: We encountered two patients with SFTS. Case 1 is a 72-year-old woman who visited our hospital 
owing to severe fatigue, diarrhea, and nausea. Her consciousness level score on the Glasgow Coma Scale was 14 
points, and her serum lactate dehydrogenase level was 646 IU/L. Case 2 is an 82-year-old woman who visited our hos-
pital owing to diarrhea and general fatigue. Her consciousness level score on the Glasgow Coma Scale was 11 points, 
and her serum lactate dehydrogenase level was 935 IU/L.
Discussion and evaluation: Both patients had hemophagocytic syndrome and presented with similar symptoms. 
Although both were treated with similar drug regimens, their clinical courses were different: after treatment, the 
72-year-old woman survived whereas the 82-year-old woman died. In addition to age, the two patients differed in 
terms of time between symptom onset and treatment initiation, consciousness level, viral load, and extent of eleva-
tion of liver enzyme levels.
Conclusions: The viral load, which is a predictor of morbidity, was associated with the level of consciousness and the 
serum lactate dehydrogenase level, both of which might be useful for predicting death in patients with SFTS.
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Background
Severe fever with thrombocytopenia syndrome (SFTS), 
an emerging infectious disease, was first reported in 
China in 2011 (Yu et al. 2011). The major clinical symp-
toms and findings of this disease include fever, emesis, 
diarrhea, lymph node swelling, neutropenia, and throm-
bocytopenia. The cause of the illness is infection with the 
SFTS virus, classified under family Bunyaviridae, genus 
Phlebovirus. The SFTS virus is transmitted by ticks, and 
hence, infection mainly occurs between early summer 
and late autumn (Zhang et  al. 2012a). The fatality rate 
for SFTS in China was approximately 30  % when the 
disease was first reported, but has fallen to 12  % owing 
to increases in the number of reported cases and con-
sequent advances in diagnostic procedures (Gai et  al. 
2012a). Supportive care remains the standard treatment.
In Japan, the first case of SFTS was reported in Janu-
ary 2013 (Takahashi et  al. 2014); since then, 166 cases 
have been registered at the National Institute of Infec-
tious Disease (Tokyo, Japan) as of December 2, 2015. 
The fatality rate in Japan is 26.5  % (of the reported 166 
patients, 44 patients died), which is higher than that in 
China (12  %). Since 2012, all cases of SFTS have been 
reported from western Japan (Takahashi et al. 2014). The 
genome sequence of the SFTS virus identified in Japan is 
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phylogenetically different from that identified in China. 
These facts demonstrate that SFTS is endemic in Japan 
and that the SFTS viruses in Japan and China evolved 
independently (Takahashi et al. 2014).
Although it was recently reported that type-I/II inter-
feron (IFN) plus ribavirin drastically reduced SFTS virus 
titers in  vitro (Shimojima et  al. 2015), a standardized 
treatment for SFTS other than supportive care has not 
yet been established. According to previous reports, the 
viral load is related to morbidity (Yoshikawa et al. 2014; 
Sun et al. 2012; Gai et al. 2012b). Herein, we report two 
patients with SFTS who visited the Toyooka Public Hos-
pital. Hemophagocytic syndrome was diagnosed in both 
patients according to the HLH2004 criteria (Henter et al. 
2007). Although both had similar symptoms including 
alterations in consciousness levels and gastrointestinal 
manifestations and received similar drug regimens, their 
clinical courses were different. The viral load correlated 
with the level of consciousness and the serum level of lac-
tate dehydrogenase (LDH). We discuss the prognosis of 
SFTS in these two cases.
Case presentation
Written informed consent was obtained from the 
patients and/or their families for publication of this case 
report and the accompanying images.
Case 1
A 72-year-old female farmer in a mountainous area was 
referred to the Public Toyooka Hospital by her family 
physician owing to fever (body temperature, approxi-
mately 38 °C), leukopenia, thrombocytopenia, and a mild 
consciousness disturbance. Four days previously, she had 
experienced severe fatigue, diarrhea, and nausea.
The patient had been receiving amlodipine at 5  mg/
day for 10  years, as prescribed by her family physician. 
Her score on the Glasgow Coma Scale (GCS) was 14 
points (eye opening, 3; verbal response, 5; and motor 
response, 6), and her vital signs were as follows: tem-
perature, 37.6  °C; pulse rate, 70 beats per minute (regu-
lar); blood pressure, 99/58  mmHg; and respiration rate, 
18 breaths per minute. A physical examination revealed 
splenomegaly and swelling of the inguinal lymph nodes. 
Contrast-enhanced computed tomography revealed 
splenomegaly and swollen axillary and inguinal lymph 
nodes. Laboratory findings were as follows: white blood 
cell (WBC) count, 1400/µL (lymphocyte count, 80/µL); 
red blood cell (RBC) count, 478  ×  104/µL; hemoglobin 
(Hb) level, 13  g/dL; platelet count, 7.2 ×  104/µL; aspar-
tate aminotransferase (AST) level, 117 IU/L; alanine ami-
notransferase (ALT) level, 33 IU/L; LDH level, 646 IU/L; 
creatinine phosphokinase (CPK) level, 595  IU/L; blood 
urea nitrogen (BUN) level, 26.4  mg/dL; serum creati-
nine (Cr) level, 0.89  mg/dL; fibrinogen level, 134.2  mg/
dL; fasting triglyceride level, 256  mg/dL; soluble inter-
leukin-2 receptor (sIL-2R) level, 1320  U/mL (normal, 
149–519  U/mL); and ferritin level, 1908  ng/mL. A cap-
illary blood smear test showed no abnormal cells. A 
bone marrow aspiration smear showed that RBCs were 
ingested by macrophages (Fig. 1). The patient met six of 
the eight HLH2004 diagnostic criteria and was therefore 
diagnosed with hemophagocytic syndrome and admit-
ted to the hospital. Although a workup was performed 
to determine the cause of this syndrome, no previously 
Fig. 1 Bone marrow smear findings for case 1. Red blood cells are 
ingested by a macrophage (May-Giemsa staining, ×400 magnifica-
tion)
Fig. 2 Tick biting the left popliteal fossa in case 1. The patient had red 
flares around the bite site
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described etiologic agents or diseases were detected (e.g., 
malignant lymphoma, Epstein-Barr virus, human immu-
nodeficiency virus, systemic lupus erythematosus, adult-
onset Still’s disease, and rheumatoid arthritis).
The following day, a tick was found attached to the skin 
of the left popliteal fossa (Fig. 2).
The tick appeared to be swollen and was constantly 
biting the patient; it was subsequently removed by using 
fine-tipped tweezers. Hence, the patient was suspected 
of having SFTS. A viral genome detection test was per-
formed via reverse transcription–polymerase chain reac-
tion (RT–PCR; Yoshikawa et  al. 2014) using total RNA 
extracted from a peripheral blood sample, a pharyngeal 
swab, and a urine specimen obtained on the day after 
admission. Three days after the initial test (hospital day 
5), the test was repeated for whole blood and urine speci-
mens. In the pharyngeal swab, the viral gene copy num-
ber (S segment) was 105.08/mL on hospital day 2 (6 days 
after disease onset). In the whole blood, the viral gene 
copy number was 104.43/mL on hospital day 2, but had 
decreased to 102.92/mL on hospital day 5.
Prior to the first viral genome detection test, the 
patient began treatment with 60  mg (1  mg/kg) predni-
solone orally for hemophagocytic syndrome and 100 mg 
minocycline twice a day intravenously for a suspected 
Rickettsial infection. Four days after treatment initia-
tion, her symptoms improved, and 5 days after treatment 
initiation, the whole blood cell count, liver enzyme lev-
els (AST, ALT, and LDH), and ferritin values returned to 
normal. Ten days after admission, the tick was identified 
as Haemaphysalis longicornis, and a definitive diagnosis 
of SFTS was made by conventional viral genome ampli-
fication analysis (Fig. 3; Yoshikawa et  al. 2014). The test 
results showed that the viral genome was amplified in 
the serum and swab specimens collected on hospital day 
2. In the second test after treatment, the viral genome 
could not be amplified from the urine specimen col-
lected on hospital day 5. By this time, prednisolone and 
minocycline treatment had been terminated because 
hemophagocytic syndrome was cured and the result of 
the Rickettsial infection test was negative. Subsequently, 
the results of a whole blood test were normal, and the 
patient’s general status was significantly improved.
Following the treatment, the patient was discharged 
from the hospital, returned to her usual lifestyle, and 
remains symptom-free in the 2 years post-treatment.
Case 2
An 82-year-old woman visited a primary care clinic 
owing to diarrhea and general fatigue.
She had hypertension but received no treatment at this 
time in the clinic. Because she was senseless and list-
less, she was referred to a community hospital on the 
following day. The results of a complete blood count were 
as follows: WBC count, 1060/µL (lymphocyte count, 
230/µL); RBC count, 348 × 104/µL; Hb level, 10.3 g/dL; 
and platelet count, 5.1 ×  104/µL. On the same day, she 
was referred to the Division of General Medicine at the 
hospital for further evaluation and treatment. When she 
presented at the hospital, her consciousness level was 
defined as groggy [GCS, 11 points (eye opening, 4; verbal 
response, 2; and motor response, 5)]. She had a body tem-
perature of 37.7  °C, a blood pressure of 125/55  mmHg, 
and a pulse rate of 93  beats/min (regular). There were 
no remarkable findings on her physical examination. The 
laboratory findings were as follows: AST level, 274 IU/L; 
ALT level, 61  IU/L; LDH level, 935  IU/L; CPK level, 
1485 IU/L; BUN level, 44.1 mg/dL; Cr level, 1.52 mg/dL; 
fibrinogen level, 126.2  mg/dL; fasting triglyceride level, 
110  mg/dL; sIL-2R level, 3030  U/mL; and ferritin level, 
3383 ng/mL. There were no remarkable findings on chest 
radiography or head computed tomography.
Fig. 3 SFTS viral genome analysis by RT-PCR for case 1. Primer sets 
were prepared for the Japanese congenital SFTS virus. To increase 
detection sensitivity, two primer sets for different target areas were 
used. Lanes 1, 3, and 5 represent the samples (serum, urine, and phar-
yngeal swab, respectively) taken on the day after admission. Lanes 2 
and 4 represent samples (serum and urine respectively) taken 3 days 
after the initial test. Lanes 6 and 7 contain a negative and positive 
control, respectively
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Abdominal computed tomography showed bilateral 
lymph node swelling in the para-aortic and inguinal 
regions. However, there was no splenomegaly. On hos-
pital day 3, 4 days after disease onset, the patient had a 
high fever and severe diarrhea. A bone marrow biopsy 
and a smear test were performed, revealing that platelet 
cells were being ingested by macrophages (Fig.  4). The 
patient met six of the eight HLH2004 diagnostic criteria, 
and hence, hemophagocytic syndrome was diagnosed. 
Although a workup was performed to determine the 
cause of this syndrome, no previously described etiologic 
agents or diseases were detected. Methylprednisolone 
at 1000  mg/day was administered for three consecutive 
days, and cefepime at 2 g was administered intravenously 
thrice daily. However, the patient’s general condition 
worsened, and the results of the laboratory tests were 
exacerbated. On hospital day 6, the laboratory results 
were as follows: WBC count, 5900/µL; RBC count, 332/
µL; platelet count, 1.9 ×  104/µL; LDH level, 1583  IU/L; 
BUN level, 114.8  mg/dL; and Cr level, 4.58  mg/dL. The 
patient’s condition deteriorated progressively, and she 
died on hospital day 8. The patient’s family was informed, 
and an autopsy was performed.
Histological analysis revealed hemophagocytic lesions 
in multiple organs. There was no evidence of malignancy. 
As the patient had died, a frozen peripheral blood serum 
collected on hospital day 2 (3  days after disease onset) 
was tested for SFTS viral genome amplification via RT-
PCR, and amplification was observed (Fig. 5). The patient 
was retrospectively diagnosed with SFTS. The viral gene 
copy number was 1 ×  107.09. There was no evidence of 
tick bites in the patient. Discussion and evaluation
Herein, we describe two patients who were diagnosed 
with SFTS; one patient survived (patient 1) and the other 
died (patient 2). There were two main differences in the 
clinical course of these patients. First, their consciousness 
levels in the acute phase (within the first week of onset) 
differed: a GCS of 14 points in the patient who survived 
and a GCS of 11 points in the patient who died. Although 
both patients were immediately treated with steroids at 
our hospital, their response to therapy was different. Pos-
sible explanations include the following: (1) patient 2 
was admitted to our hospital later than patient 1 relative 
to the onset of symptoms, and thus, her treatment was 
delayed, (2) patient 2 had higher levels of liver enzymes 
and CPK during the course of treatment than did patient 
1, and (3) patient 2 was older than patient 1. In addition, 
central nerve system manifestations, particularly lethargy 
and coma, are correlated with mortality (Gai et al. 2012a).
In the patient who survived, the consciousness level 
normalized after steroid therapy.
Laboratory parameters also normalized within 12 days 
after symptom onset. In the patient who died, the 
Fig. 4 Bone marrow smear findings for case 2. Platelets are ingested 
by a macrophage (May-Giemsa staining, ×400 magnification)
Fig. 5 SFTS viral genome analysis by RT-PCR for case 2. Primer sets 
were prepared for the Japanese congenital SFTS virus. To increase 
detection sensitivity, two primer sets for different target areas were 
used. Lane 1 represents a frozen serum specimen, lane 2 contains a 
negative control, and lane 3 contains a positive control
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consciousness level deteriorated with time, and the lab-
oratory parameters worsened, particularly the platelet 
counts, liver enzyme levels, CPK levels, and renal func-
tion test measurements. These differences in the clini-
cal course may be related to the viral load (Yoshikawa 
et  al. 2014). The viral gene copy number was low and 
decreased immediately in the patient who survived but 
not in the patient who died. Viral load is related to mor-
bidity (Yoshikawa et  al. 2014; Sun et  al. 2012; Gai et  al. 
2012b) and may therefore correlate with consciousness 
level, which could therefore be used to predict death in 
SFTS patients. In contrast to consciousness level, which 
is quickly and easily assessed, determination of viral gene 
copy number requires several days, and laboratory tests 
for viral load can only be performed at a limited num-
ber of inspection institutes (for example, the National 
Institute of Infectious Disease). In addition, a recent 
study showed that increased AST, LDH and CPK levels, 
decreased lymphocyte percentages, and older ages were 
significantly associated with the death of patients with 
SFTS (Sun et  al. 2012; Zhang et  al. 2012b; Deng et  al. 
2013; Cui et al. 2013).
The two patients described in this report were simi-
lar in that both had hemophagocytic syndrome, which 
has been shown to correlate with cytokine levels and 
the severity of SFTS (Sun et al. 2012). Steroids are tradi-
tionally administered for treatment of hemophagocytic 
syndrome in many cases, but the efficacy is unclear. Usu-
ally, hemophagocytic syndrome occurs following other 
conditions, most notably lymphoma and Epstein-Barr 
virus infection. In such cases, a patient receives a specific 
therapy: chemotherapy for malignant lymphoma and 
an etoposide-containing regimen for Epstein-Barr virus 
infection associated with severe hemophagocytic syn-
drome (Jordan et al. 2011). These causes did not apply to 
the patients in our report, and therefore, these therapies 
were not chosen.
The specific treatment for SFTS has not been estab-
lished. A recent study showed that administration of 
ribavirin or tetracycline did not prolong the survival of 
SFTS patients (Liu et al. 2013). Combined usage of type-
I/II IFN and ribavirin drastically reduced SFTS virus 
infection in vitro and therefore may be useful in the treat-
ment of SFTS (Shimojima et  al. 2015). When a case of 
SFTS is diagnosed, supportive care should be provided to 
improve the general condition of the patient.
Conclusions
We encountered two cases of SFTS; one patient survived 
but the other died. Differences between the clinical and 
biological parameters of the two patients included age, 
time of treatment relative to symptom onset, level of con-
sciousness, LDH level, and CPK level. We suggest that 
viral load is an important predictor of morbidity and is 
associated with the level of consciousness and the serum 
LDH level. As shown in our previous report, these param-
eters correlated with SFTS prognosis, and they may there-
fore be useful for predicting death in SFTS patients.
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